RUNX1T1 and acute myeloid leukemia: They identified that cyclooxygenase 2 (COX-2) and β-catenin pathways were downstream of AML1-ETO and that HDAC inhibition by trichostatin A could therapeutically target the AML-like effects in the zebrafish model (Figure 1C).